IntroductionPsoriasis is a chronic disease involving the skin, which significantly impacts the quality of life. Disease severity and treatment efficacy (i.e., response) are assessed through the Psoriasis Area and Severity Index (PASI). A PASI 75 response,
Paulina Maravilla-Herrera +17 more
exaly +3 more sources
Health utility by Psoriasis Area and Severity Index response status after biologic induction therapy in Chinese patients with moderate to severe psoriasis [PDF]
Aim: Psoriasis severely affects quality of life, particularly in patients with moderate to severe psoriasis. This study aims to estimate health utility by Psoriasis Area and Severity Index (PASI) response after biologic induction therapy in Chinese ...
Lu Jian +10 more
doaj +2 more sources
PASI 90 y PASI absoluto: ¿por qué debemos cambiar las metas de tratamiento en psoriasis?
Introducción: En 2011, el PASI 75 fue definido por un consenso europeo como la meta de tratamiento en los pacientes con psoriasis y adoptado por diferentes guías de práctica clínica alrededor del mundo.
Natalia Hernández Mantilla +1 more
doaj +3 more sources
PREVALENCE OF MTHFR GENE 677C>T POLYMORPHISM IN THE PATIENTS WITH PSORIASIS VULGARIS [PDF]
The study aimed to investigate the relationship between carriage of 677C>T polymorphism in the gene of methylene tetrahydrofolate reductase (MTHFR) and plaque psoriasis in patients in Bulgaria.
Borislav Dimitrov +3 more
doaj +1 more source
Study of serum Ceruloplasmin, Malondialdehyde (MDA) and hs-CRP as biomarkers of severity in Psoriasis [PDF]
Background : Psoriasis is one of the common diseases diagnosed in dermatology clinics. It is characterized by erythematous and sharply demarcated papules covered by silvery micaceous scales.
1. K Prashanth, Assistant Professor, Department of Biochemistry, Rajiv Gandhi Institute of Medical Sciences [RIMS], Adilabad, Telangana State, India. 2. MohdInayatulla Khan, Assistant Professor, Department of Physiology, Rajiv Gandhi Institute of Medical Sciences [RIMS], Adilabad, Telangana State, India.
doaj +1 more source
Background: Psoriasis is a chronic, inflammatory, immune-mediated, debilitating skin disease affecting approximately 2%–3% of the global population.
Saikat Banerjee +3 more
doaj +1 more source
Correlation between psoriasis severity and dyslipidaemia in Iraqi patients [PDF]
Background/Aim: Psoriasis is a persistent systemic disorder characterised by chronic inflammation and linked to multiple comorbidities, including arthritis, cardiometabolic disorders, obesity and hyperlipidaemia.
Jasim Samar Ahmed +3 more
doaj +1 more source
Narrowband Ultraviolet B (NB-UVB) Phototherapy in Psoriasis: A Retrospective Study
Background: Psoriasis with higher Psoriasis Area and Severity Index (PASI) scores correlate with impaired quality of life. Assessing narrowband ultraviolet B (NB-UVB) phototherapy as a new therapy option in Indonesia is necessary to find the most ...
Faida Ufaira Prameswari +1 more
doaj +1 more source
Psoriasis Area and Severity Index response in moderate-severe psoriatic patients switched to adalimumab: results from the OPPSA study [PDF]
Background: Few studies have compared the efficacy of switching to adalimumab in the real-life setting in plaque psoriasis patients. Objective: To evaluate the effect of adalimumab in psoriasis patients previously treated with other biologics.
Armesto +40 more
core +1 more source
Use of the psoriasis epidemiology screening tool (PEST) to identify psoriatic arthritis in Bosnia and Herzegovina [PDF]
Background/Aim: Psoriatic arthritis (PsA) is chronic inflammatory disease with estimated prevalence of 6 % to 41 % in patients with psoriasis. The aim of this study was to determine the prevalence of PsA in Bosnian patients with psoriasis in everyday ...
Petković-Dabić Jelena +3 more
doaj +1 more source

